FDA Approved: VALGANCICLOVIR — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for valganciclovir from Ajanta Pharma USA Inc., confirming regulatory approval of a generic valganciclovir product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Cytomegalovirus Retinitis

Drugs mentioned

• Valganciclovir (Valganciclovir)

Snippet

SUPPL AP for VALGANCICLOVIR (VALGANCICLOVIR)